1. Home
  2. AIRE vs CRDL Comparison

AIRE vs CRDL Comparison

Compare AIRE & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIRE
  • CRDL
  • Stock Information
  • Founded
  • AIRE 2021
  • CRDL 2017
  • Country
  • AIRE United States
  • CRDL Canada
  • Employees
  • AIRE N/A
  • CRDL 18
  • Industry
  • AIRE
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AIRE
  • CRDL Health Care
  • Exchange
  • AIRE Nasdaq
  • CRDL Nasdaq
  • Market Cap
  • AIRE 86.1M
  • CRDL 80.1M
  • IPO Year
  • AIRE N/A
  • CRDL N/A
  • Fundamental
  • Price
  • AIRE $0.65
  • CRDL $1.08
  • Analyst Decision
  • AIRE Strong Buy
  • CRDL Strong Buy
  • Analyst Count
  • AIRE 1
  • CRDL 3
  • Target Price
  • AIRE $3.00
  • CRDL $9.00
  • AVG Volume (30 Days)
  • AIRE 252.6K
  • CRDL 196.4K
  • Earning Date
  • AIRE 05-23-2025
  • CRDL 05-13-2025
  • Dividend Yield
  • AIRE N/A
  • CRDL N/A
  • EPS Growth
  • AIRE N/A
  • CRDL N/A
  • EPS
  • AIRE N/A
  • CRDL N/A
  • Revenue
  • AIRE $948,420.00
  • CRDL N/A
  • Revenue This Year
  • AIRE $206.83
  • CRDL N/A
  • Revenue Next Year
  • AIRE $158.08
  • CRDL N/A
  • P/E Ratio
  • AIRE N/A
  • CRDL N/A
  • Revenue Growth
  • AIRE 419.58
  • CRDL N/A
  • 52 Week Low
  • AIRE $0.52
  • CRDL $0.77
  • 52 Week High
  • AIRE $4.49
  • CRDL $3.12
  • Technical
  • Relative Strength Index (RSI)
  • AIRE 33.13
  • CRDL 55.77
  • Support Level
  • AIRE $0.60
  • CRDL $0.92
  • Resistance Level
  • AIRE $0.85
  • CRDL $1.08
  • Average True Range (ATR)
  • AIRE 0.07
  • CRDL 0.10
  • MACD
  • AIRE 0.02
  • CRDL 0.02
  • Stochastic Oscillator
  • AIRE 40.27
  • CRDL 93.92

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company that develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability; and has an app for investment into the properties that it purchased aimed at retail investors. The company's reportable segments are; Platform Services, which derives key revenue, and the Rental business segment.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: